4-anilino-3-quinolinecarbonitriles for the treatment of...

Details 4-anilino-3-quinolinecarbonitriles for the treatment of... 4-anilino-3-quinolinecarbonitriles for the treatment of...

2004-11-03

2008-08-26

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S157000, C546S153000, C514S313000, C514S253060

Reexamination Certificate

active

07417148

ABSTRACT:
Compounds of the formula:wherein:n is an integer from 1-3;X is N, CH, provided that when X is N, n is 2 or 3;R is alkyl of 1 to 3 carbon atoms;R1is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt;R2is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.

REFERENCES:
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6780996 (2004-08-01), Boschelli et al.
patent: WO 03/093241 (2003-11-01), None
patent: WO 2004/075898 (2004-09-01), None
Boschelli, J Med Chem, 2001, vol. 44, pp. 822-833.
Boschelli, J Med Chem, 2001, vol. 44 pp. 3965-3977.
Registry comopund No. 220127-57-1, Mar. 3, 1999.
Berger, D., et al.; Substituted 4-Anilino-7-phenyl-3-quinolinecarbonitriles as Src Kinase Inhibitors; Bioorg. Med. Chem. Lett. 12:2989-2992 (2002).
Boschelli, D.H.; et al.; J. Med. Chem. 44:3965-3911 (2001).
Boschelli, D.H.; et al.; J. Med. Chem. 47:1599-1601 (2004).
Boschelli, D.H., et al.; J. Med. Chem. 44:822-833 (2001).
Boschelli, D.H., et al.; Bioorganic & Medicinal Chemistry Letters 13:3797-3800 (2003).
Golas, J.M.; et al.; Cancer Research 63:375-381 (Jan. 15, 2003).
Ye, F.; 221stNational Meeting of the American Chemical Society, San Diego (Apr. 2001).
Huy, et al., “Requirement of Src kinases Lyn, Hck and Fgr forBCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia”, Nature Genetics, vol. 36, (2004) pp. 453-461.

Affiliated with

Also associated with

Rating

4-anilino-3-quinolinecarbonitriles for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-anilino-3-quinolinecarbonitriles for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-anilino-3-quinolinecarbonitriles for the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3994684